Trial
NCT02727998
Intensive 7-day Treatment for PTSD Combining Ketamine With Exposure Therapy
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Yale University
Collaborators
—
Condition
Posttraumatic Stress Disorder
Intervention
Ketamine
Why stopped
Study ran out of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-10-17